Cartesian Therapeutics, Inc. (RNAC)
9.55
-0.42
(-4.21%)
USD |
NASDAQ |
Aug 28, 16:00
9.55
0.00 (0.00%)
After-Hours: 19:29
Cartesian Therapeutics EPS Diluted (TTM) : -5.939 for June 30, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -5.939 |
| March 31, 2026 | -5.798 |
| December 31, 2025 | -5.023 |
| September 30, 2025 | -2.59 |
| June 30, 2025 | -0.6681 |
| March 31, 2025 | -11.76 |
| September 30, 2024 | -52.64 |
| June 30, 2024 | -53.26 |
| March 31, 2024 | -56.02 |
| December 31, 2023 | -49.77 |
| September 30, 2023 | -9.710 |
| June 30, 2023 | -9.515 |
| March 31, 2023 | -5.551 |
| December 31, 2022 | 5.454 |
| September 30, 2022 | 9.915 |
| June 30, 2022 | 6.803 |
| March 31, 2022 | 6.196 |
| December 31, 2021 | -7.235 |
| September 30, 2021 | -14.49 |
| June 30, 2021 | -12.60 |
| March 31, 2021 | -21.20 |
| Date | Value |
|---|---|
| December 31, 2020 | -20.75 |
| September 30, 2020 | -24.99 |
| June 30, 2020 | -29.97 |
| March 31, 2020 | -33.47 |
| December 31, 2019 | -36.68 |
| September 30, 2019 | -47.72 |
| June 30, 2019 | -61.39 |
| March 31, 2019 | -75.65 |
| December 31, 2018 | -87.56 |
| September 30, 2018 | -94.38 |
| June 30, 2018 | -92.75 |
| March 31, 2018 | -93.03 |
| December 31, 2017 | -96.28 |
| September 30, 2017 | -92.98 |
| June 30, 2017 | -86.08 |
| March 31, 2017 | -143.08 |
| December 31, 2016 | -134.32 |
| September 30, 2016 | -122.95 |
| June 30, 2016 | -110.05 |
| March 31, 2016 | -27.55 |
| March 31, 2015 | -11.73 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Allogene Therapeutics, Inc. | -0.6651 |
| Beam Therapeutics, Inc. | -0.86 |
| C4 Therapeutics, Inc. | -0.9988 |
| Kyverna Therapeutics, Inc. | -2.936 |
| Arrowhead Pharmaceuticals, Inc. | -2.243 |